The Shifting Field of Stem Cell Regulations
Recent FDA Hearings Sparked by Concerns Over Growth of Clinics Offering Unapproved Therapies to Consumers
Enhancing Graduate and Postdoc Education for a Sustainable Workforce
Ph.D.-Trained Biomedical Scientists Can No Longer Count on Finding Academic Positions Upon Graduation
Unlucky 13: Top Clinical Trial Failures of 2016
In Missing Primary Endpoints, These Drugs Touched Off Stock Selloff, Layoffs, and Worse
Supplement: Therapeutic Cancer Vaccine Roundup
Individualized Cell Therapies Come with a Unique Set of Bioprocess Requirements
For full access to this article login to GEN Select now.
Oklahoma Seeks to Retain Local Research
Establishment of Life Science Cluster in This Prairie State Is Not as Far-Fetched as It Seems
- Three of the 17 drugs approved by the FDA in 2007 originated in Oklahoma. Surprised? The key word is “originated.” Projects have a strong tendency to originate in Oklahoma’s laboratories but be developed elsewhere. Alexion is a classic example. The company was formed around a project Scott Rollins, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.